| Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy. | |
| | |
MedLine Citation:
|
PMID: 10609493 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Survival of patients with advanced stage malignant mixed mullerian tumor of the ovary is poor and the best treatment remains unknown. A 62-year-old woman diagnosed with stage IIIC heterologous malignant mixed mullerian tumor of the ovary underwent optimal cytoreductive surgery followed by paclitaxel (135 mg/m2 over 24 hours) and cisplatin (75 mg/m2) every 4 weeks for 6 courses. The patient tolerated chemotherapy well, had complete clinical response and remained without disease for 21 months following diagnosis. Paclitaxel and cisplatin may be effective in malignant mixed mullerian tumors of the ovary. |
| | |
Authors:
|
G H Eltabbakh; R Yadav |
Related Documents
:
|
12453853 - Phase i/ii study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy ... 12399133 - A phase ii study of non-platinum based chemotherapy with paclitaxel and vinorelbine in ... 21123833 - Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European journal of gynaecological oncology Volume: 20 ISSN: 0392-2936 ISO Abbreviation: Eur. J. Gynaecol. Oncol. Publication Date: 1999 |
Date Detail:
|
Created Date: 2000-01-18 Completed Date: 2000-01-18 Revised Date: 2006-04-24 |
Medline Journal Info:
|
Nlm Unique ID: 8100357 Medline TA: Eur J Gynaecol Oncol Country: ITALY |
Other Details:
|
Languages: eng Pagination: 355-6 Citation Subset: IM |
Affiliation:
|
Division of Gynecolgic Oncology, The University of Vermont, Burlington 05401, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents, Phytogenic
/
therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use* Cisplatin / therapeutic use Female Humans Middle Aged Mixed Tumor, Mullerian / drug therapy*, pathology, surgery Neoplasm Staging Ovarian Neoplasms / drug therapy*, pathology, surgery Paclitaxel / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Phytogenic; 15663-27-1/Cisplatin; 33069-62-4/Paclitaxel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Internal jugular phlebectasia in children.
Next Document: The prognostic value of peritoneal cytology in ovarian cancer.